EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-dose and standard-dose whole-body [18F]FDG-PET/CT imaging: implications for healthy controls and lung cancer patients

Daria Ferrara, Lalith Kumar Shiyam Sundar, Zacharias Chalampalakis, Barbara Katharina Geist, Daniela Gompelmann, Sebastian Gutschmayer, Marcus Hacker, Hunor Kertész, Kilian Kluge, Marco Idzko, Werner Langsteger, Josef Yu und 2 weitere

Frontiers in Physics · 04.04.2024 · 12

DOI: 10.3389/fphy.2024.1378521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physics, online erschienen am 04.04.2024. Verfasst von Daria Ferrara und 13 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

High-sensitivity hybrid positron emission tomography (PET) imaging using advanced whole-body (WB) or total-body PET/computed tomography (CT) systems permits reducing injected tracer activity while preserving diagnostic quality. Such approaches are promising for healthy control studies or exploring inter-organ communication in systemic diseases. This study assessed test/retest variations in the fluoro-2-deoxy-D-glucose (FDG) uptake in key organs from low-dose (LD) and standard-dose (STD) [18F]FDG-PET/CT imaging protocols in healthy controls and lung cancer patients.

Methods

A total of 19 healthy controls (19–62 years, 46–104 kg, 10 M/9 F) and 7 lung cancer patients (47–77 years, 50–88 kg, 4 M/3 F) underwent [18F]FDG-PET/CT imaging. All subjects were first injected (“test,” LD) with 28 ± 2 MBq FDG and underwent a dynamic (0–67 min post-injection) WB imaging protocol with LD-CT. Then, 90 min post-LD injection, the subjects were repositioned and injected with 275 ± 16 MBq FDG (“retest,” STD). Second LD-CT and STD-CT scans were acquired for healthy controls and patients, respectively. Static images (55–67 min post-injection) were considered for subsequent analysis. The CT images were used to automatically segment the target volumes of interest. Standardized uptake values normalized to the body weight (SUV BW ) were extracted for each volume of interest. The mean SUV BW were compared for both LD/STD conditions with paired t-tests. In patients, FDG-avid lesions were manually delineated on LD and STD static images. Effective dose levels were estimated from both the CT and PET acquisitions.

Results

Organ-based mean SUV BW were similar between the LD and STD (mean %difference ≤5%) in both healthy controls and cancer patients, except in the heart. Intra-control test/retest variability was significant in the brain, heart, and skeletal muscle ( p < 0.05). While 17 lesions were delineated on the STD images of the patients, only 10/17 lesions were identified on the LD images due to increased image noise. Lesion-based mean SUV BW were similar between LD and STD acquisitions ( p = 0.49, %difference = 10%). In patients, the effective doses were (1.9 ± 0.2) mSv (LD-CT), (16.6 ± 5.4) mSv (STD-CT), (0.5 ± 0.1) mSv (LD-PET), and (4.6 ± 0.3) mSv (STD-PET).

Conclusion

LD and STD [18F]FDG injections in healthy controls and lung cancer patients yielded comparable mean SUV BW , except in the heart. Dose levels may be reduced for [18F]FDG-PET imaging without a loss in mean SUV BW accuracy, promoting LD-PET/CT protocols for studying multi-organ metabolic patterns. In oncology patients, this approach may be hindered by a lower diagnostic quality in the presence of significant noise.

Zitieren

APA

Ferrara, D., Sundar, L. K. S., Chalampalakis, Z., Geist, B. K., Gompelmann, D., Gutschmayer, S., Hacker, M., Kertész, H., Kluge, K., Idzko, M., Langsteger, W., Yu, J., Rausch, I., & Beyer, T. (2024). Low-dose and standard-dose whole-body [18F]FDG-PET/CT imaging: implications for healthy controls and lung cancer patients. Frontiers in Physics, 12. https://doi.org/10.3389/fphy.2024.1378521

Vancouver

Ferrara D, Sundar LKS, Chalampalakis Z, Geist BK, Gompelmann D, Gutschmayer S, et al. Low-dose and standard-dose whole-body [18F]FDG-PET/CT imaging: implications for healthy controls and lung cancer patients. Frontiers in Physics. 2024;12. doi:10.3389/fphy.2024.1378521

BibTeX
@article{Ferrara2024,
  author = {Ferrara, Daria and Sundar, Lalith Kumar Shiyam and Chalampalakis, Zacharias and Geist, Barbara Katharina and Gompelmann, Daniela and Gutschmayer, Sebastian and Hacker, Marcus and Kertész, Hunor and Kluge, Kilian and Idzko, Marco and Langsteger, Werner and Yu, Josef and Rausch, Ivo and Beyer, Thomas},
  title = {Low-dose and standard-dose whole-body [18F]FDG-PET/CT imaging: implications for healthy controls and lung cancer patients},
  journal = {Frontiers in Physics},
  year = {2024},
  volume = {12},
  doi = {10.3389/fphy.2024.1378521}
}
Kostenlos starten →